![CPHI Barcelona](https://pharma-bavaria.com/wp-content/uploads/2023/10/Picture-CPHI-2023-1080x675.png)
![CPHI Barcelona](https://pharma-bavaria.com/wp-content/uploads/2023/10/Picture-CPHI-2023-1080x675.png)
![CPhI Worldwide 2021](https://pharma-bavaria.com/wp-content/uploads/2021/10/CPhI-site.png)
CPhI Worldwide 2021
Pharma Bavaria International will attend CPhI Worldwide 2021, scheduled from 9-11 November of 2021, in Fiera Milano, Milan, Italy. Together with co-located events, CPhI Worldwide will have more than 1,400 exhibitors offering pharma products, services, and solutions...![Pharma Bavaria Int. further extends its partnership for Combofusiv™ (AFT’s innovative Paracetamol/Ibuprofen IV formulation) to Sub-Saharan African markets.](https://pharma-bavaria.com/wp-content/uploads/2021/09/Partnership-Africa.png)
Pharma Bavaria Int. further extends its partnership for Combofusiv™ (AFT’s innovative Paracetamol/Ibuprofen IV formulation) to Sub-Saharan African markets.
After Central America, the Caribbean and Latin America, Pharma Bavaria International is expanding the territory of its brand Combofusiv™ (AFT’s brand: Maxigesic® IV) to additional 38 markets in Sub-Saharan Africa by signing an extension to the license agreement with...![Pharma Bavaria Int. expands its partnership for Combofusiv™ (Maxigesic® IV), AFT’s innovative Paracetamol/Ibuprofen IV formulation in South America.](https://pharma-bavaria.com/wp-content/uploads/2021/05/Partnership-1.png)
Pharma Bavaria Int. expands its partnership for Combofusiv™ (Maxigesic® IV), AFT’s innovative Paracetamol/Ibuprofen IV formulation in South America.
Pharma Bavaria International is expanding the territory of its brand Combofusiv™ (AFT’s Maxigesic® IV) to Colombia, Peru, Chile, Ecuador, Bolivia, and Uruguay by signing an extension of a license agreement with the New Zealand based company AFT Pharmaceuticals. The...![Pray for India](https://pharma-bavaria.com/wp-content/uploads/2021/05/Pray-for-India-site.png)
Pray for India
Hope, love, and prayers to India 🙏 The severity of the COVID19 situation in India during the last few weeks has been very difficult and heartbreaking. The pandemic is affecting millions of families across the country. We are sending our prayers and love to India, to...![2021 DUPHAT exhibition](https://pharma-bavaria.com/wp-content/uploads/2021/04/Duphat-booth.png)
2021 DUPHAT exhibition
Last week we attend the 2021 DUPHAT in DWTC, Dubai!Dubai Pharmaceutical & Technologies Conference & Exhibition is known to be the most sought-after event for key decision-makers in the Pharmaceutical Industry in the Middle East & Africa as it features the...![Training Session | Cyprus](https://pharma-bavaria.com/wp-content/uploads/2021/02/caden-training-final-1080x675.png)
Training Session | Cyprus
Another training session this year, this time for our partner in Cyprus’ market regarding a hospital product in the cardiology area. This training session had the objective to share the scientific knowledge that we have with our local colleagues and support...![Training Session | Iran Market](https://pharma-bavaria.com/wp-content/uploads/2021/02/formacao-1080x675.png)
Training Session | Iran Market
In line with the claim of “bridge builders”, we intend to support our partners with the scientific know-how and marketing strategy of our products. So, we consider that the training sessions that we do are “plus” on the local team’s...![Training Session | Product Launch](https://pharma-bavaria.com/wp-content/uploads/2021/02/Coartil-UAE-Header--1080x505.jpg)
Training Session | Product Launch
With a vast portfolio, we are constantly launching new products in different markets. So, we feel that we should share the scientific knowledge that we have with our local colleagues and support them with the key topics and selling proposition of each product. With...![SEASON’S GREETINGS | WE ALWAYS BELIEVE THAT](https://pharma-bavaria.com/wp-content/uploads/2021/02/SG2020-Header-100-1080x505.jpg)